
Sep 15, 2026
Sep 15, 2026
A conversation with Brooks Leitner on making functional health measures more accessible
A conversation with Brooks Leitner on making functional health measures more accessible



What if one of the most important measures of long-term health could come from a blood test instead of a performance lab?
Brooks Leitner (Founder & CEO, VO Health) joins Aman for a conversation about building the next generation of biomarker testing around functional measures of health. Drawing on his experiences in medicine, scientific research, and venture capital, Brooks explains how VO Health is using multi-omics technology to make gold-standard measures of human function more accessible.
The conversation explores how the company narrowed thousands of measurable proteins into a smaller set of reliable signals, and the tradeoffs involved in turning complex biological data into something people can actually understand and use.
Beyond the technology, Brooks and Aman discuss a broader question facing consumer health: how much information is actually useful? From clinician interpretation and coaching to AI-generated insights, they explore how biomarker testing could become more accessible while still giving people meaningful guidance about what to do with their results.

What if one of the most important measures of long-term health could come from a blood test instead of a performance lab?
Brooks Leitner (Founder & CEO, VO Health) joins Aman for a conversation about building the next generation of biomarker testing around functional measures of health. Drawing on his experiences in medicine, scientific research, and venture capital, Brooks explains how VO Health is using multi-omics technology to make gold-standard measures of human function more accessible.
The conversation explores how the company narrowed thousands of measurable proteins into a smaller set of reliable signals, and the tradeoffs involved in turning complex biological data into something people can actually understand and use.
Beyond the technology, Brooks and Aman discuss a broader question facing consumer health: how much information is actually useful? From clinician interpretation and coaching to AI-generated insights, they explore how biomarker testing could become more accessible while still giving people meaningful guidance about what to do with their results.
